Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.36%, Hang Seng Futures +0.55%, ASX SPI 200 +0.24%, S&P Futures +0.10%

Sep 28 ,2025

  • Synopsis:

    • Asian markets set for positive start to Monday trade. Futures signaling opening gains in Japan, Hong Kong and Australia. S&P 500 futures little changed after US indexes registered small weekly declines. Australian bonds touch stronger after Treasury yields rose slightly on Friday. FX markets steady after dollar capped off modest weekly advance against majors. Crude weaker amid reports OPEC+ weighing larger production hike for November. Gold coming off Friday's highs. Bitcoin unchanged near three-week low.

    • On trade front, Reuters sources noted White House weighing tariffs on foreign electronics based on percentage of number of chips they possess in bid to reduce reliance on foreign imports. Comes after media reports on Friday highlighted plans to push firms to produce same number of chips in US as their customers import from overseas producers. Trump's threat to impose 100% tariffs om pharma imports blunted by subsequent reports tariffs won't apply to countries with negotiated trade deals. Elsewhere, senior South Korean official said country unable to invest $350B with cash given insufficient FX reserves. US reportedly told India tariff relief contingent on reducing Russian crude purchases.

    • Quiet Monday ahead before busy macro stretch with official China PMIs (Tues) forecast to show manufacturing stuck in contraction while non-manufacturing activity stalled. Weekend data showed China industrial profits rebounded in August. RBA (Tues) expected to leave interest rates unchanged as economists cast doubt on November rate cut amid rising inflation. September BOJ Tankan (Wed) comes as markets dial up odds of an October rate hike. BOJ Governor Ueda will also speak Friday. US nonfarm payrolls (Fri) forecast to show another soft headline jobs result with market pricing in ~80% chance of October rate cut..

  • Pre-open Company News:

    • 600713.CH -- Guangzhou Baiyunshan Pharmaceutical to acquire 11.0% stake in Nanjing Pharmaceutical at CNY5.18/share

    • 000627.CH -- Hubei Biocause Pharmaceutical to delist from Shenzhen Stock Exchange, effective 30-Sep

    • 867.HK -- NMPA approves China Medical System's MG-K10 for phase III trial in chronic spontaneous urticaria

    • 1709.HK -- DL Holdings Group acquires Bitcoin mining machines for $21.9M via convertible bonds and warrants

    • SML.NZ -- Synlait Milk reports FY underlying NPAT NZ$0.8M vs guidance of breakeven

    • 9899.HK -- NetEase Cloud Music initiated hold at HSBC

    • 7113.MK -- Top Glove Corp. upgraded to outperform from hold at CLSA

    • 4911.JP -- Shiseido initiated neutral at UBS

    • 1877.HK -- Shanghai Junshi Biosciences downgraded to neutral from buy at UBS

    • 9899.HK -- NetEase Cloud Music initiated buy at UBS

    • 4551.JP -- Japan Tobacco finalises transfer of Torii Pharmaceutical to Shionogi & Co, effective 1-Dec-25

    • 6888.MK -- Axiata Group upgraded to overweight from equal-weight at Morgan Stanley

    • 1113.HK -- CK Asset Holdings upgraded to buy from neutral at BofA

    • 500510.IN -- Larsen & Toubro downgraded to underperform from buy at BofA

    • CLSA initiates SICC H/A-shares with outperform ratings

  • On Deck:

    • Hong Kong:

      • Earnings:

        • 160 Health International (2656.HK)

    • Japan:

      • Economic:

        • 14:00 JST: Leading Index (Final); consensus

      • Earnings:

        • SHIMAMURA (8227.JP)

    • Australia:

      • Earnings:

        • Polymetals Resources (POL.AU), Strike Energy (STX.AU)

  • Market Data:

    • Gold (Dec 25): ($11.10) or (0.29%) to $3797.90

    • WTI Crude (Nov 25): ($0.68) or (1.03%) to $65.04

    • $-¥: (0.01) or (0.00%) to 149.5030

    • $-KRW: (0.97) or (0.07%) to 1408.7100

    • A$-$: +0.00 or +0.13% to 0.6551

    • $-INR: (0.00) or (0.00%) to 88.6768

    • $-CNY: (0.00) or (0.01%) to 7.1328

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE